<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2017-05-10" version="186">
<accession>Q13177</accession>
<accession>Q13154</accession>
<accession>Q6ISC3</accession>
<name>PAK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein kinase PAK 2</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Gamma-PAK</fullName>
</alternativeName>
<alternativeName>
<fullName>PAK65</fullName>
</alternativeName>
<alternativeName>
<fullName>S6/H4 kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>p21-activated kinase 2</fullName>
<shortName>PAK-2</shortName>
</alternativeName>
<alternativeName>
<fullName>p58</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>PAK-2p27</fullName>
<shortName>p27</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>PAK-2p34</fullName>
<shortName>p34</shortName>
</recommendedName>
<alternativeName>
<fullName>C-t-PAK2</fullName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">PAK2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1995-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Sells M."/>
<person name="Knause U.J."/>
<person name="Bagrodia S."/>
<person name="Ambrose D."/>
<person name="Bokoch G.M."/>
<person name="Chernoff J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="1970" last="1978">
<title>A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20.</title>
<authorList>
<person name="Martin G.A."/>
<person name="Bollag G."/>
<person name="McCormick F."/>
<person name="Abo A."/>
</authorList>
<dbReference type="PubMed" id="7744004"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 32-524</scope>
<scope>PROTEIN SEQUENCE OF 401-417</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="4385" last="4385">
<authorList>
<person name="Martin G.A."/>
<person name="Bollag G."/>
<person name="McCormick F."/>
<person name="Abo A."/>
</authorList>
<dbReference type="PubMed" id="7556080"/>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="21121" last="21128">
<title>Activation of an S6/H4 kinase (PAK 65) from human placenta by intramolecular and intermolecular autophosphorylation.</title>
<authorList>
<person name="Benner G.E."/>
<person name="Dennis P.B."/>
<person name="Masaracchia R.A."/>
</authorList>
<dbReference type="PubMed" id="7673144"/>
<dbReference type="DOI" id="10.1074/jbc.270.36.21121"/>
</citation>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Science" volume="276" first="1571" last="1574">
<title>Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2.</title>
<authorList>
<person name="Rudel T."/>
<person name="Bokoch G.M."/>
</authorList>
<dbReference type="PubMed" id="9171063"/>
<dbReference type="DOI" id="10.1126/science.276.5318.1571"/>
</citation>
<scope>CASPASE-3 CLEAVAGE AT ASP-512</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-212</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="28733" last="28739">
<title>Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity.</title>
<authorList>
<person name="Walter B.N."/>
<person name="Huang Z."/>
<person name="Jakobi R."/>
<person name="Tuazon P.T."/>
<person name="Alnemri E.S."/>
<person name="Litwack G."/>
<person name="Traugh J.A."/>
</authorList>
<dbReference type="PubMed" id="9786869"/>
<dbReference type="DOI" id="10.1074/jbc.273.44.28733"/>
</citation>
<scope>CASPASE-3 CLEAVAGE AT ASP-512</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LYS-278 AND THR-402</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Virol." volume="74" first="11081" last="11087">
<title>Lentivirus Nef specifically activates Pak2.</title>
<authorList>
<person name="Arora V.K."/>
<person name="Molina R.P."/>
<person name="Foster J.L."/>
<person name="Blakemore J.L."/>
<person name="Chernoff J."/>
<person name="Fredericksen B.L."/>
<person name="Garcia J.V."/>
</authorList>
<dbReference type="PubMed" id="11070003"/>
<dbReference type="DOI" id="10.1128/JVI.74.23.11081-11087.2000"/>
</citation>
<scope>INTERACTION WITH HIV-1 NEF</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="38675" last="38685">
<title>Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation.</title>
<authorList>
<person name="Jakobi R."/>
<person name="McCarthy C.C."/>
<person name="Koeppel M.A."/>
<person name="Stringer D.K."/>
</authorList>
<dbReference type="PubMed" id="12853446"/>
<dbReference type="DOI" id="10.1074/jbc.M306494200"/>
</citation>
<scope>FUNCTION (PAK-2P34)</scope>
<scope>UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 239-ILE--GLY-243 AND 246-LYS--LYS-248</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="38649" last="38657">
<title>Phosphorylation of Mnk1 by caspase-activated Pak2/gamma-PAK inhibits phosphorylation and interaction of eIF4G with Mnk.</title>
<authorList>
<person name="Orton K.C."/>
<person name="Ling J."/>
<person name="Waskiewicz A.J."/>
<person name="Cooper J.A."/>
<person name="Merrick W.C."/>
<person name="Korneeva N.L."/>
<person name="Rhoads R.E."/>
<person name="Sonenberg N."/>
<person name="Traugh J.A."/>
</authorList>
<dbReference type="PubMed" id="15234964"/>
<dbReference type="DOI" id="10.1074/jbc.M407337200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MKNK1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="53653" last="53664">
<title>Identification and characterization of PS-GAP as a novel regulator of caspase-activated PAK-2.</title>
<authorList>
<person name="Koeppel M.A."/>
<person name="McCarthy C.C."/>
<person name="Moertl E."/>
<person name="Jakobi R."/>
</authorList>
<dbReference type="PubMed" id="15471851"/>
<dbReference type="DOI" id="10.1074/jbc.M410530200"/>
</citation>
<scope>INTERACTION WITH ARHGAP10</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="EMBO Rep." volume="7" first="186" last="191">
<title>Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome.</title>
<authorList>
<person name="Kaerkkaeinen S."/>
<person name="Hiipakka M."/>
<person name="Wang J.-H."/>
<person name="Kleino I."/>
<person name="Vaehae-Jaakkola M."/>
<person name="Renkema G.H."/>
<person name="Liss M."/>
<person name="Wagner R."/>
<person name="Saksela K."/>
</authorList>
<dbReference type="PubMed" id="16374509"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400596"/>
</citation>
<scope>INTERACTION WITH SH3MD4</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="6542" last="6547">
<title>Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events.</title>
<authorList>
<person name="Vilas G.L."/>
<person name="Corvi M.M."/>
<person name="Plummer G.J."/>
<person name="Seime A.M."/>
<person name="Lambkin G.R."/>
<person name="Berthiaume L.G."/>
</authorList>
<dbReference type="PubMed" id="16617111"/>
<dbReference type="DOI" id="10.1073/pnas.0600824103"/>
</citation>
<scope>FUNCTION (PAK-2P34)</scope>
<scope>MYRISTOYLATION AT GLY-213 (PAK-2P34)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Hum. Mol. Genet." volume="17" first="3552" last="3565">
<title>Scrib regulates PAK activity during the cell migration process.</title>
<authorList>
<person name="Nola S."/>
<person name="Sebbagh M."/>
<person name="Marchetto S."/>
<person name="Osmani N."/>
<person name="Nourry C."/>
<person name="Audebert S."/>
<person name="Navarro C."/>
<person name="Rachel R."/>
<person name="Montcouquiol M."/>
<person name="Sans N."/>
<person name="Etienne-Manneville S."/>
<person name="Borg J.-P."/>
<person name="Santoni M.-J."/>
</authorList>
<dbReference type="PubMed" id="18716323"/>
<dbReference type="DOI" id="10.1093/hmg/ddn248"/>
</citation>
<scope>INTERACTION WITH SCRIB</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-141 AND THR-169</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="2816" last="2827">
<title>Dual role of Cdc42 in spindle orientation control of adherent cells.</title>
<authorList>
<person name="Mitsushima M."/>
<person name="Toyoshima F."/>
<person name="Nishida E."/>
</authorList>
<dbReference type="PubMed" id="19273597"/>
<dbReference type="DOI" id="10.1128/MCB.01713-08"/>
</citation>
<scope>INTERACTION WITH ARHGEF7 AND GIT1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141 AND SER-197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-128</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="287" last="301">
<title>Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration.</title>
<authorList>
<person name="Hsu R.M."/>
<person name="Tsai M.H."/>
<person name="Hsieh Y.J."/>
<person name="Lyu P.C."/>
<person name="Yu J.S."/>
</authorList>
<dbReference type="PubMed" id="19923322"/>
<dbReference type="DOI" id="10.1091/mbc.E09-03-0232"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-141</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="2689" last="2695">
<title>Mechanistic studies of the autoactivation of PAK2: a two-step model of cis initiation followed by trans amplification.</title>
<authorList>
<person name="Wang J."/>
<person name="Wu J.W."/>
<person name="Wang Z.X."/>
</authorList>
<dbReference type="PubMed" id="21098037"/>
<dbReference type="DOI" id="10.1074/jbc.M110.156505"/>
</citation>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="13603" last="13611">
<title>Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.</title>
<authorList>
<person name="De la Mota-Peynado A."/>
<person name="Chernoff J."/>
<person name="Beeser A."/>
</authorList>
<dbReference type="PubMed" id="21317288"/>
<dbReference type="DOI" id="10.1074/jbc.M110.181743"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MAPK4 AND MAPK6</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Carcinogenesis" volume="32" first="659" last="666">
<title>P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation.</title>
<authorList>
<person name="Li T."/>
<person name="Zhang J."/>
<person name="Zhu F."/>
<person name="Wen W."/>
<person name="Zykova T."/>
<person name="Li X."/>
<person name="Liu K."/>
<person name="Peng C."/>
<person name="Ma W."/>
<person name="Shi G."/>
<person name="Dong Z."/>
<person name="Bode A.M."/>
<person name="Dong Z."/>
</authorList>
<dbReference type="PubMed" id="21177766"/>
<dbReference type="DOI" id="10.1093/carcin/bgq271"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF JUN</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Genes Dev." volume="25" first="1359" last="1364">
<title>Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome assembly.</title>
<authorList>
<person name="Kang B."/>
<person name="Pu M."/>
<person name="Hu G."/>
<person name="Wen W."/>
<person name="Dong Z."/>
<person name="Zhao K."/>
<person name="Stillman B."/>
<person name="Zhang Z."/>
</authorList>
<dbReference type="PubMed" id="21724829"/>
<dbReference type="DOI" id="10.1101/gad.2055511"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HISTONE H4</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-141 AND THR-169</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-20; SER-55; SER-58; THR-60; SER-64; THR-134; SER-141; THR-143; THR-154; THR-169 AND SER-197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-139 AND SER-141</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Nature" volume="469" first="107" last="111">
<title>The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold.</title>
<authorList>
<person name="Selyunin A.S."/>
<person name="Sutton S.E."/>
<person name="Weigele B.A."/>
<person name="Reddick L.E."/>
<person name="Orchard R.C."/>
<person name="Bresson S.M."/>
<person name="Tomchick D.R."/>
<person name="Alto N.M."/>
</authorList>
<dbReference type="PubMed" id="21170023"/>
<dbReference type="DOI" id="10.1038/nature09593"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.86 ANGSTROMS) OF 121-136</scope>
</reference>
<comment type="function">
<text evidence="18 19 22 25 26 27 28 29">Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation. Acts as downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Full-length PAK2 stimulates cell survival and cell growth. Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration. Phosphorylates JUN and plays an important role in EGF-induced cell proliferation. Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP. Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis. On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway. Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="12">Activated by binding small G proteins. Binding of GTP-bound CDC42 or RAC1 to the autoregulatory region releases monomers from the autoinhibited dimer, enables phosphorylation of Thr-402 and allows the kinase domain to adopt an active structure (By similarity). Following caspase cleavage, autophosphorylated PAK-2p34 is constitutively active.</text>
</comment>
<comment type="subunit">
<text evidence="17 20 21 23 24">Interacts tightly with GTP-bound but not GDP-bound CDC42/p21 and RAC1. Interacts with SH3MD4. Interacts with and activated by HIV-1 Nef. Interacts with SCRIB. Interacts with ARHGEF7 and GIT1. PAK-2p34 interacts with ARHGAP10.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-1045887"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-1642523">
<id>Q15052</id>
<label>ARHGEF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-717515">
<id>Q14155</id>
<label>ARHGEF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-3649585">
<id>O55043</id>
<label>Arhgef7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-523958">
<id>P55210</id>
<label>CASP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-81752">
<id>P60953</id>
<label>CDC42</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-444403">
<id>P53667</id>
<label>LIMK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-413628">
<id>P63000</id>
<label>RAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-6285694">
<id>Q9H4E5</id>
<label>RHOJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-7975674">
<id>Q8TEJ3</id>
<label>SH3RF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-433642">
<id>Q9BX66</id>
<label>SORBS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-311323">
<id>O94875</id>
<label>SORBS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-741237">
<id>O60504</id>
<label>SORBS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1045887"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Serine/threonine-protein kinase PAK 2</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>MYO18A mediates the cellular distribution of the PAK2-ARHGEF7-GIT1 complex to the inner surface of the cell membrane.</text>
</comment>
<comment type="subcellular location">
<molecule>PAK-2p34</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
<topology>Lipid-anchor</topology>
</subcellularLocation>
<text>Interaction with ARHGAP10 probably changes PAK-2p34 location to cytoplasmic perinuclear region. Myristoylation changes PAK-2p34 location to the membrane.</text>
</comment>
<comment type="tissue specificity">
<text>Ubiquitously expressed. Higher levels seen in skeletal muscle, ovary, thymus and spleen.</text>
</comment>
<comment type="PTM">
<text>Full length PAK2 is autophosphorylated when activated by CDC42/p21. Following cleavage, both peptides, PAK-2p27 and PAK-2p34, become highly autophosphorylated, with PAK-2p27 being phosphorylated on serine and PAK-2p34 on threonine residues, respectively. Autophosphorylation of PAK-2p27 can occur in the absence of any effectors and is dependent on phosphorylation of Thr-402, because PAK-2p27 is acting as an exogenous substrate.</text>
</comment>
<comment type="PTM">
<text>During apoptosis proteolytically cleaved by caspase-3 or caspase-3-like proteases to yield active PAK-2p34.</text>
</comment>
<comment type="PTM">
<text evidence="18">Ubiquitinated, leading to its proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="22">PAK-2p34 is myristoylated.</text>
</comment>
<comment type="similarity">
<text evidence="31">Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PAK2ID41634ch3q29.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="U24153">
<property type="protein sequence ID" value="AAA65442.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC069613">
<property type="protein sequence ID" value="AAH69613.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U25975">
<property type="protein sequence ID" value="AAA75468.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3321.1"/>
<dbReference type="PIR" id="S58682">
<property type="entry name" value="S58682"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002568.2">
<property type="nucleotide sequence ID" value="NM_002577.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011511172.1">
<property type="nucleotide sequence ID" value="XM_011512870.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016861990.1">
<property type="nucleotide sequence ID" value="XM_017006501.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.518530"/>
<dbReference type="PDB" id="3PCS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.86"/>
<property type="chains" value="E/F/G/H=121-136"/>
</dbReference>
<dbReference type="PDBsum" id="3PCS"/>
<dbReference type="ProteinModelPortal" id="Q13177"/>
<dbReference type="SMR" id="Q13177"/>
<dbReference type="BioGrid" id="111098">
<property type="interactions" value="84"/>
</dbReference>
<dbReference type="DIP" id="DIP-38249N"/>
<dbReference type="IntAct" id="Q13177">
<property type="interactions" value="47"/>
</dbReference>
<dbReference type="MINT" id="MINT-235655"/>
<dbReference type="STRING" id="9606.ENSP00000314067"/>
<dbReference type="BindingDB" id="Q13177"/>
<dbReference type="ChEMBL" id="CHEMBL4487"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2134"/>
<dbReference type="iPTMnet" id="Q13177"/>
<dbReference type="PhosphoSitePlus" id="Q13177"/>
<dbReference type="SwissPalm" id="Q13177"/>
<dbReference type="BioMuta" id="PAK2"/>
<dbReference type="DMDM" id="143811432"/>
<dbReference type="OGP" id="Q13177"/>
<dbReference type="EPD" id="Q13177"/>
<dbReference type="MaxQB" id="Q13177"/>
<dbReference type="PaxDb" id="Q13177"/>
<dbReference type="PeptideAtlas" id="Q13177"/>
<dbReference type="PRIDE" id="Q13177"/>
<dbReference type="DNASU" id="5062"/>
<dbReference type="Ensembl" id="ENST00000327134">
<property type="protein sequence ID" value="ENSP00000314067"/>
<property type="gene ID" value="ENSG00000180370"/>
</dbReference>
<dbReference type="GeneID" id="5062"/>
<dbReference type="KEGG" id="hsa:5062"/>
<dbReference type="UCSC" id="uc003fwy.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5062"/>
<dbReference type="DisGeNET" id="5062"/>
<dbReference type="GeneCards" id="PAK2"/>
<dbReference type="H-InvDB" id="HIX0030815"/>
<dbReference type="HGNC" id="HGNC:8591">
<property type="gene designation" value="PAK2"/>
</dbReference>
<dbReference type="HPA" id="CAB007794"/>
<dbReference type="MIM" id="605022">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13177"/>
<dbReference type="OpenTargets" id="ENSG00000180370"/>
<dbReference type="PharmGKB" id="PA32918"/>
<dbReference type="eggNOG" id="KOG0578">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XP4K">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00860000133680"/>
<dbReference type="HOGENOM" id="HOG000234202"/>
<dbReference type="HOVERGEN" id="HBG108518"/>
<dbReference type="InParanoid" id="Q13177"/>
<dbReference type="KO" id="K04410"/>
<dbReference type="OMA" id="MTSASHK"/>
<dbReference type="OrthoDB" id="EOG091G04H8"/>
<dbReference type="PhylomeDB" id="Q13177"/>
<dbReference type="TreeFam" id="TF105351"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-164944">
<property type="pathway name" value="Nef and signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202433">
<property type="pathway name" value="Generation of second messenger molecules"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211728">
<property type="pathway name" value="Regulation of PAK-2p34 activity by PS-GAP/RHG10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211733">
<property type="pathway name" value="Regulation of activated PAK-2p34 by proteasome mediated degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211736">
<property type="pathway name" value="Stimulation of the cell death response by PAK-2p34"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871796">
<property type="pathway name" value="FCERI mediated MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389359">
<property type="pathway name" value="CD28 dependent Vav1 pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928664">
<property type="pathway name" value="Ephrin signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-399954">
<property type="pathway name" value="Sema3A PAK dependent Axon repulsion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-428540">
<property type="pathway name" value="Activation of Rac"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218920">
<property type="pathway name" value="VEGFR2 mediated vascular permeability"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5627123">
<property type="pathway name" value="RHO GTPases activate PAKs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5687128">
<property type="pathway name" value="MAPK6/MAPK4 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q13177"/>
<dbReference type="SIGNOR" id="Q13177"/>
<dbReference type="ChiTaRS" id="PAK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q13177"/>
<dbReference type="GeneWiki" id="PAK2"/>
<dbReference type="GenomeRNAi" id="5062"/>
<dbReference type="PMAP-CutDB" id="Q13177"/>
<dbReference type="PRO" id="PR:Q13177"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000180370"/>
<dbReference type="CleanEx" id="HS_PAK2"/>
<dbReference type="ExpressionAtlas" id="Q13177">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13177">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030296">
<property type="term" value="F:protein tyrosine kinase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048365">
<property type="term" value="F:Rac GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004702">
<property type="term" value="F:signal transducer, downstream of receptor, with serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031267">
<property type="term" value="F:small GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071407">
<property type="term" value="P:cellular response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060996">
<property type="term" value="P:dendritic spine development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001271">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006469">
<property type="term" value="P:negative regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016310">
<property type="term" value="P:phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001238">
<property type="term" value="P:positive regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050690">
<property type="term" value="P:regulation of defense response to virus by virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0040008">
<property type="term" value="P:regulation of growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031295">
<property type="term" value="P:T cell costimulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd01093">
<property type="entry name" value="CRIB_PAK_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.810.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000095">
<property type="entry name" value="CRIB_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033923">
<property type="entry name" value="PAK_BD"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00786">
<property type="entry name" value="PBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00285">
<property type="entry name" value="PBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50108">
<property type="entry name" value="CRIB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0021">Allosteric enzyme</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0341">Growth regulation</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0519">Myristate</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="6 7 8 9">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Serine/threonine-protein kinase PAK 2" id="PRO_0000086465">
<location>
<begin position="2"/>
<end position="524"/>
</location>
</feature>
<feature type="chain" description="PAK-2p27" id="PRO_0000304922">
<location>
<begin position="2"/>
<end position="212"/>
</location>
</feature>
<feature type="chain" description="PAK-2p34" id="PRO_0000304923">
<location>
<begin position="213"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="CRIB" evidence="14">
<location>
<begin position="74"/>
<end position="87"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="15">
<location>
<begin position="249"/>
<end position="499"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="15">
<location>
<begin position="255"/>
<end position="263"/>
</location>
</feature>
<feature type="region of interest" description="Autoregulatory region" evidence="12">
<location>
<begin position="69"/>
<end position="137"/>
</location>
</feature>
<feature type="region of interest" description="GTPase-binding" evidence="12">
<location>
<begin position="69"/>
<end position="112"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="245"/>
<end position="251"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="15 16">
<location>
<position position="367"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="15">
<location>
<position position="278"/>
</location>
</feature>
<feature type="site" description="Cleavage; by caspase-3 or caspase-3-like proteases">
<location>
<begin position="212"/>
<end position="213"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="6 7 8 9">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 6 7 10">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="55"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 10">
<location>
<position position="58"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="60"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="13">
<location>
<position position="62"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="64"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="134"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 6 7 10 11">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="154"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3 7 10">
<location>
<position position="169"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10">
<location>
<position position="197"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="31">
<location>
<position position="402"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="N-myristoyl glycine; in form PAK-2p34" evidence="22">
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits caspase-mediated cleavage." evidence="29">
<original>D</original>
<variation>N</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes myristoylation of PAK-2p34 and membrane location.">
<original>G</original>
<variation>A</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear export." evidence="18">
<original>IVSIG</original>
<variation>REGRS</variation>
<location>
<begin position="239"/>
<end position="243"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly inhibits nuclear localization." evidence="18">
<original>KKK</original>
<variation>MHE</variation>
<location>
<begin position="246"/>
<end position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity and autophosphorylation." evidence="30">
<original>K</original>
<variation>R</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity and greatly inhibits autophosphorylation of PAK-2p27 and PAK-2p34." evidence="30">
<original>T</original>
<variation>A</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA75468." ref="3" evidence="31">
<original>A</original>
<variation>T</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA65442." ref="1" evidence="31">
<original>F</original>
<variation>L</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA65442." ref="1" evidence="31">
<original>T</original>
<variation>P</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAH69613." ref="2" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA75468." ref="3" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA65442." ref="1" evidence="31">
<original>T</original>
<variation>TA</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="123"/>
<end position="126"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PCS"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8CIN4"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00057"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11070003"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12853446"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15234964"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15471851"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16374509"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16617111"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18716323"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19273597"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19923322"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21177766"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21317288"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21724829"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9171063"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9786869"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<sequence length="524" mass="58043" checksum="00A7CD15F93D4180" modified="2007-04-03" version="3">
MSDNGELEDKPPAPPVRMSSTIFSTGGKDPLSANHSLKPLPSVPEEKKPRHKIISIFSGT
EKGSKKKEKERPEISPPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKLEQKKNP
QAVLDVLKFYDSNTVKQKYLSFTPPEKDGFPSGTPALNAKGTEAPAVVTEEEDDDEETAP
PVIAPRPDHTKSIYTRSVIDPVPAPVGDSHVDGAAKSLDKQKKKTKMTDEEIMEKLRTIV
SIGDPKKKYTRYEKIGQGASGTVFTATDVALGQEVAIKQINLQKQPKKELIINEILVMKE
LKNPNIVNFLDSYLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH
ANQVIHRDIKSDNVLLGMEGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY
GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC
LEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLIMAAKEAMKSNR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>